Patent ID: 11911375
Assignee: FERTIN PHARMA A/S
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A solid oral nicotine formulation comprising
a nicotine-ion exchange resin combination,
and a salt comprising inorganic divalent cations,
wherein the salt is present as a separate component,
wherein the solid oral nicotine formulation comprises divalent cations in molar ratio of 0.1 to 5 relative to the amount of nicotine in the nicotine-ion exchange resin combination,
wherein the solid oral nicotine formulation is selected from the group consisting of a lozenge, a chewable tablet, and a chewing gum,
wherein the ion exchange resin comprises a copolymer of methacrylic acid and divinylbenzene, said copolymer containing carboxylic functional groups, and
wherein the salt is selected from the group consisting of calcium chloride and magnesium chloride, or combinations thereof.